495 related articles for article (PubMed ID: 19013342)
1. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
Solé A
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
[TBL] [Abstract][Full Text] [Related]
2. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
4. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
[TBL] [Abstract][Full Text] [Related]
5. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
[TBL] [Abstract][Full Text] [Related]
6. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
Mohammad RA; Klein KC
Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
[TBL] [Abstract][Full Text] [Related]
7. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
Perfect JR; Dodds Ashley E; Drew R
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
Ho KM; Duff O; Chambers D; Murray R
Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
[TBL] [Abstract][Full Text] [Related]
11. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
12. Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data.
Muñoz P; Guinea J; Narbona MT; Bouza E
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S125-31. PubMed ID: 19013336
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
[TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
15. Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
Drew R
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():36-44. PubMed ID: 16713192
[TBL] [Abstract][Full Text] [Related]
16. A survey of anti-fungal management in lung transplantation.
Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
18. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
19. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A
J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
[TBL] [Abstract][Full Text] [Related]
20. Fungal infections after lung transplantation.
Solé A; Salavert M
Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]